Successful drug discovery. Volume 5 /
| Other Authors: | , , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Weinheim, Germany :
Wiley-VCH,
[2021]
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book. |
Table of Contents:
- Drug discovery in academia
- From degraders to molecular glues : new ways of breaking down disease-associated proteins
- GLP-1 receptor agonists for the treatment of type 2 diabetes and obesity
- Recent advances on SGLT2 inhibitors : synthetic approaches, therapeutic benefits, and adverse events
- CAR T cells : a novel biological drug class
- CGRP inhibitors for the treatment of migraine
- Discovery and development of Emicizumab (HEMLIBRA) : a humanized bispecific antibody to coagulation factors IXa and X with a factor VIII cofactor activity
- Discovery and development of Ivosidenib (AG-120 : TIBSOVO)
- The discovery of Kisqali (Ribociclib) : a CDK4/6 inhibitor for the treatment of HR+/HER2- advanced breast cancer.